PARIS (Reuters) – Healthcare and clinical diagnostics company Novacyt, whose shares have surged on the back of its COVID-19 testing products, announced on Thursday the launch of three new products to support testing for the presence of the virus.
Novacyt, whose Paris-listed shares are up nearly 1,500% since the start of 2020, said its new products were ‘Exsig™ Direct’, ‘Exsig™ Mag’ and ‘COVID-HT’.
“As we continue to supply our COVID-19 test to laboratories around the world, we are delighted to provide further support through the launch of these new products,” said Novacyt CEO Graham Mullis.
Reporting by Sudip Kar-Gupta; Editing by Mark Potter
vCard.red is a free platform for creating a mobile-friendly digital business cards. You can easily create a vCard and generate a QR code for it, allowing others to scan and save your contact details instantly.
The platform allows you to display contact information, social media links, services, and products all in one shareable link. Optional features include appointment scheduling, WhatsApp-based storefronts, media galleries, and custom design options.